VKTX icon

Viking Therapeutics

140 hedge funds and large institutions have $230M invested in Viking Therapeutics in 2020 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 49 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

less ownership

Funds ownership:

21% less capital invested

Capital invested by funds: $290M → $230M (-$60M)

31% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 49

Holders
140
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$8.28M
Puts
$2.76M
Net Calls
Net Calls Change

Top Buyers

1 +$4.55M
2 +$2.03M
3 +$1.47M
4
SG Americas Securities
SG Americas Securities
New York
+$1.36M
5
Morgan Stanley
Morgan Stanley
New York
+$1.01M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$46.5M
2
$29.4M
3
$27.4M
4
$19.3M
5
$9.31M
6
$8.48M
7
$8.08M
8
$6.56M
9
$5.52M
10
$4.13M
11
$3.64M
12
$2.92M
13
$2.62M
14
$2.35M
15
$2.21M
16
$2.03M
17
$1.99M
18
$1.99M
19
$1.96M
20
$1.94M
21
$1.87M
22
$1.82M
23
$1.76M
24
$1.75M
25
$1.75M